Hosted on MSN
Indivior signals 2025 SUBLOCADE net revenue guidance of $725M-$765M amid expanded investments
CEO Mark Crossley stated that Q1 financial results were in line with expectations, despite a 6% year-on-year decline in total net revenue, largely driven by intensified competition in SUBOXONE Film ...
The cost of Sublocade injection can vary based on several factors, including your insurance coverage. Copay assistance programs can also lower the price you’ll pay for Sublocade. As with all ...
Hosted on MSN
Indivior outlines $1.03B–$1.08B 2025 revenue guidance and cost structure overhaul through action agenda
CEO Joseph J. Ciaffoni reported record SUBLOCADE net revenue, led by solid U.S. performance, stating "Our top line performance positions us well for the remainder of the year and enables us to raise ...
The company raised its 2025 guidance, with Ciaffoni indicating, "We now expect total net revenue in 2025 to be up versus 2024, driven by SUBLOCADE growth of 10% at the midpoint." Preblick stated, "Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results